万泰生物：公司重组三价轮状病毒亚单位疫苗（大肠埃希菌）采用全新的技术路线

Core Viewpoint - Wantai Biological (603392) has announced the development of a new trivalent rotavirus subunit vaccine (E. coli) utilizing a novel technological approach, which theoretically offers a broader range of protection [1] Company Summary - The company is focusing on innovative vaccine technology to enhance the effectiveness and coverage of its products [1]